Abstract:Purpose: The levels of reactive oxygen species (ROS) in tumor cells are much higher than that in normal cells, and rise rapidly under the influence of exogenous or endogenous inducing factors, eventually leading to the apoptosis of tumor cells. Therefore, this study prepared a dual pH/reducing-responsive poly (N-isopropylacrylamide-co-Cinnamaldehyde-co-D-α-tocopheryl polyethylene glycol 1000 succinate, PssNCT) nanogels, which employed two exogenous ROS inducers, cinnamaldehyde (CA) and D-α-tocopheryl polyethylene glycol 1000 succinate (TPGS), to selectively induce apoptosis by regulating ROS levels in tumor cells. Methods: The PssNCT nanogels were prepared by the free radical precipitation polymerization under the crosslink between pH-sensitive hydrazone and reducing-sensitive disulfide bonds, followed by the physicochemical and morphological characteristics investigations. Plasma stability, dual pH/reducing responsive degradation and in vitro release were also assessed. In cell experiments, cytotoxicity in different cells were first detected. The intracellular ROS levels and mitochondrial functions of tumor cells were then evaluated. Moreover, the apoptosis and western-blot assays were employed to verify the association between ROS levels elevation and apoptosis in tumor cells. Results: The nanogels exhibited a round-like hollow structure with the diameter smaller than 200nm. The nanogels were stable in plasma, while showed rapid degradation in acidic and reducing environments, thus achieving significant release of CA and TPGS in these media. Furthermore, the sufficient amplification of ROS signals was induced by the synergistically function of CA and TPGS on mitochondria, which resulted in the opening of the mitochondrial apoptotic pathway and enhanced cytotoxicity on MCF-7 cells. However, nanogels barely affected L929 cells owing to their lower intracellular ROS basal levels. Conclusion: The specific ROS regulation method achieved by these nanogels could be explored to selectively kill tumor cells according to the difference of ROS signals in different kinds of cells.

Amplification of Oxidative Stress in MCF-7 Cells by a Novel Ph-Responsive Amphiphilic Micellar System Enhances Anticancer Therapy.

Tumor-targeted Hyaluronic Acid-Based Oxidative Stress Nanoamplifier with ROS Generation and GSH Depletion for Antitumor Therapy.

Investigation of the Intracellular Oxidative Stress Amplification, Safety and Anti-Tumor Effect of a Kind of Novel Redox-Responsive Micelle

Synergistic Amplification of Oxidative Stress-Mediated Antitumor Activity Via Liposomal Dichloroacetic Acid and MOF-Fe2+

Intelligent Nanocatalyst Mediated Lysosomal Ablation Pathway to Coordinate the Amplification of Tumor Treatment

Oxidative Stress Amplifiers As Immunogenic Cell Death Nanoinducers Disrupting Mitochondrial Redox Homeostasis for Cancer Immunotherapy.

A pH-sensitive imidazole grafted polymeric micelles nanoplatform based on ROS amplification for ferroptosis-enhanced chemodynamic therapy

An Oxidative Stress Nano-Amplifier for Improved Tumor Elimination and Combined Immunotherapy

A Mitochondria-Targeting ROS-activated Nanoprodrug for Self-Augmented Antitumor Oxidation Therapy

Reduction-sensitive Polymeric Micelles As Amplifying Oxidative Stress Vehicles for Enhanced Antitumor Therapy

A multimodal therapeutic nano-prodrug as oxidative stress amplifier induces apoptosis and ferroptosis for cancer therapy

Nanostructured Peptidotoxins As Natural Pro-Oxidants Induced Cancer Cell Death Via Amplification of Oxidative Stress.

Hydrogen peroxide-responsive anticancer hyperbranched polymer micelles for enhanced cell apoptosis

Photo-Activated Oxidative Stress Amplifier: A Strategy for Targeting Glutathione Metabolism and Enhancing ROS-Mediated Therapy in Triple-Negative Breast Cancer Treatment.

Hypoxia and pH co-triggered oxidative stress amplifier for tumor therapy

Regulating Intracellular ROS Signal by a Dual Ph/reducing-Responsive Nanogels System Promotes Tumor Cell Apoptosis

pH-Responsive Micellar Nanoparticles for the Delivery of a Self-Amplifying ROS-Activatable Prodrug

Amplification of Oxidative Stress Via Intracellular ROS Production and Antioxidant Consumption by Two Natural Drug-Encapsulated Nanoagents for Efficient Anticancer Therapy

Acidity-responsive nanocages as robust reactive oxygen species generators with butterfly effects for maximizing oxidative damage and enhancing cancer therapy

Mesoporous Polydopamine Nanoplatforms Loaded with Calcium Ascorbate for Amplified Oxidation and Photothermal Combination Cancer Therapy

pH and ROS sequentially responsive podophyllotoxin prodrug micelles with surface charge-switchable and self-amplification drug release for combating multidrug resistance cancer